How many institutions held ENTX - Entera Bio Ltd. - Ordinary Shares, par value of NIS 0.0000769 in Q1 2026?

26 institutional investors reported ENTX - Entera Bio Ltd. - Ordinary Shares, par value of NIS 0.0000769 for Q1 2026. Use the holders table for investor-level position and value details.

Entera Bio Ltd. - Ordinary Shares, par value of NIS 0.0000769 (ENTX)

Q: What does CUSIP M40527109 represent in this 13F holders report?

CUSIP M40527109 is the security identifier for ENTX - Entera Bio Ltd. - Ordinary Shares, par value of NIS 0.0000769 used to aggregate holder disclosures.

CUSIP: M40527109

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Ordinary Shares, par value of NIS 0.0000769
Total 13F shares: 7,871,783
Total 13F value: $8,677,875
Share change: -1,471,094
SEC-reported price per share: $1.11
Number of holders: 26
Value change: -$1,722,017
Number of buys: 13
Number of sells: 11
Shares outstanding: 173,760,059

Security key

M40527109

Report period

Q1 2026

Institutions

Top holders

ENTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Entera Bio Ltd. SEC filings Entera Bio Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP M40527109

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026 Q1 2026

Ownership snapshot

Top reported holders of ENTX - Entera Bio Ltd. - Ordinary Shares, par value of NIS 0.0000769 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

OPKO HEALTH, INC.

Disclosed value leader

Knoll Capital Management,...

Comparable rows

2/15

Latest evidence

01 Jan 2026

13D/G 13F 3/4/5 Lead comparable stake: 8.1% 13 rows are not safely comparable across share classes. 13D/G row: OPKO HEALTH, INC. Showing 1-6 of 15 holder rows.

Quick read

OPKO HEALTH, INC. leads the comparable SEC ownership view at 8.1%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens OPKO HEALTH, INC.'s linked filing trail.

Comparable ownership Top 2

OPKO HEALTH, INC. 8.1%

Point72 Asset Management, L.P. 2.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
OPKO HEALTH, INC.	13D/G 13D/G	8.1% Reported 13D/G · 16 Mar 2025	$8,660,281 3,685,226 shares	$0	16 Mar 2025
Point72 Asset Management, L.P.	13F 13D/G Company 13F 13D/G	2.6% Reported 13D/G · 30 Sep 2025	$2,315,687 1,193,653 shares	—	31 Dec 2025
Knoll Capital Management, LLC	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	— denominator unverified	$11,410,845 5,881,879 shares	—	31 Dec 2025
MARSHALL WACE, LLP	13F Company 13F	— denominator unverified	$1,217,020 627,330 shares	—	31 Dec 2025
Schonfeld Strategic Advisors LLC	13F Company 13F	— denominator unverified	$1,157,374 596,585 shares	—	31 Dec 2025
Gerald M. Lieberman	3/4/5 Director 3/4/5	— mixed-class rows	$823,723 406,668 shares mixed-class rows	—	01 Jan 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

7,871,783

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Holder diff

Investor	Q1 2026 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q1 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend